Exact Mass: 362.0750124

Exact Mass Matches: 362.0750124

Found 39 metabolites which its exact mass value is equals to given mass value 362.0750124, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fosphenytoin

(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl dihydrogen phosphate

C16H15N2O6P (362.06677)


Fosphenytoin is a water-soluble phenytoin prodrug used only in hospitals for the treatment of epileptic seizures. It works by slowing down impulses in the brain that cause seizures. Its main mechanism is to block frequency-dependent, use-dependent and voltage-dependent neuronal sodium channels, and therefore limit repetitive firing of action potentials. N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AB - Hydantoin derivatives C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D049990 - Membrane Transport Modulators

   

7-O-Galloyl-sedoheptulose

(2,3,4,5,7-Pentahydroxy-6-oxoheptyl) 3,4,5-trihydroxybenzoate

C14H18O11 (362.0849078)


   
   

Tephcalostan

8,9-Methylenedioxy-5-(1-methylethenyl)-4,5-dihydrofurano[2,3:3,2]-coumestan

C21H14O6 (362.0790344)


   

14-Methoxyhalenaquinone

14-Methoxyhalenaquinone

C21H14O6 (362.0790344)


   
   
   
   

15-methoxyhalenaquinone

15-methoxyhalenaquinone

C21H14O6 (362.0790344)


   

5-(4,4,6-trimethyl-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)naphthalene-2-sulfonic acid

5-(4,4,6-trimethyl-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)naphthalene-2-sulfonic acid

C17H18N2O3S2 (362.0758798)


   

ethyl 3-(N-(5-chloro-2-nitrophenyl)anilino)-3-oxopropanoate

ethyl 3-(N-(5-chloro-2-nitrophenyl)anilino)-3-oxopropanoate

C17H15ClN2O5 (362.06694500000003)


   
   

7-chloro-1-(2,3-dihydroxypropyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one

7-chloro-1-(2,3-dihydroxypropyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one

C18H16ClFN2O3 (362.08334279999997)


   

n-(2-hydroxyethyl)ethylenediaminetriacetic acid, trisodium salt hydrate, 85

n-(2-hydroxyethyl)ethylenediaminetriacetic acid, trisodium salt hydrate, 85

C10H17N2Na3O8 (362.06779620000003)


   

4-[3-(3,4-dicyanophenoxy)phenoxy]benzene-1,2-dicarbonitrile

4-[3-(3,4-dicyanophenoxy)phenoxy]benzene-1,2-dicarbonitrile

C22H10N4O2 (362.08037199999995)


   

4-BENZYLOXY-5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)-PYRIMIDINE

4-BENZYLOXY-5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)-PYRIMIDINE

C16H19BrN4O (362.07421439999996)


   

Piperazine-1,4-bis(2-hydroxypropanesulfonic acid) dihydrate

Piperazine-1,4-bis(2-hydroxypropanesulfonic acid) dihydrate

C10H22N2O8S2 (362.0817532)


   

4-(dimethylsulfamoyl)-N-[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]benzamide

4-(dimethylsulfamoyl)-N-[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]benzamide

C15H14N4O5S (362.06848740000004)


   

1,5-Dihydroxy-4,8-bis(hydroxy(hydroxymethyl)amino)anthraquinone

1,5-Dihydroxy-4,8-bis(hydroxy(hydroxymethyl)amino)anthraquinone

C16H14N2O8 (362.0750124)


   

6-(1,3-benzodioxol-5-yl)-N-(2-thiazolylmethyl)-4-quinazolinamine

6-(1,3-benzodioxol-5-yl)-N-(2-thiazolylmethyl)-4-quinazolinamine

C19H14N4O2S (362.0837424)


   

2-[(5-cyano-4-oxo-6-phenyl-1H-pyrimidin-2-yl)thio]-N-phenylacetamide

2-[(5-cyano-4-oxo-6-phenyl-1H-pyrimidin-2-yl)thio]-N-phenylacetamide

C19H14N4O2S (362.0837424)


   

3-[(1,3-benzothiazol-2-ylthio)methyl]-4-cyclohexyl-1H-1,2,4-triazole-5-thione

3-[(1,3-benzothiazol-2-ylthio)methyl]-4-cyclohexyl-1H-1,2,4-triazole-5-thione

C16H18N4S3 (362.06935480000004)


   

8-Chloro-7-[2-(4-methoxyphenyl)-2-oxoethyl]-1,3-dimethylpurine-2,6-dione

8-Chloro-7-[2-(4-methoxyphenyl)-2-oxoethyl]-1,3-dimethylpurine-2,6-dione

C16H15ClN4O4 (362.07817800000004)


   

Cefadroxil(1-)

Cefadroxil(1-)

C16H16N3O5S- (362.0810626)


A cephalosporin carboxylic acid anion having a 7beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino side-chain, formed by proton loss from the carboxy group of the cephalosporin cefadroxil.

   

2-[4,6-dihydroxy-2-methoxy-3-[(E)-3-methyl-4-sulfooxybut-2-enyl]phenyl]acetic acid

2-[4,6-dihydroxy-2-methoxy-3-[(E)-3-methyl-4-sulfooxybut-2-enyl]phenyl]acetic acid

C14H18O9S (362.06714980000004)


   

2-[4,6-Dihydroxy-2-methoxy-3-(3-methylbut-2-enyl)phenyl]-2-sulooxyacetic acid

2-[4,6-Dihydroxy-2-methoxy-3-(3-methylbut-2-enyl)phenyl]-2-sulooxyacetic acid

C14H18O9S (362.06714980000004)


   

Fosphenytoin

(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl dihydrogen phosphate

C16H15N2O6P (362.06677)


N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AB - Hydantoin derivatives C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D049990 - Membrane Transport Modulators

   

ZINC00784494

ZINC00784494

C20H14N2O3S (362.07250940000006)


ZINC00784494 is a specific Lipocalin-2 (LCN2) inhibitor. ZINC00784494 inhibits cell proliferation, cell viability and reduces AKT phosphorylation levels in SUM149 cells. ZINC00784494 has good potential for research in inflammatory breast cancer (IBC)[1].

   

methyl 2-(4-hydroxy-3-{[2-hydroxy-5-(2-methoxy-2-oxoethyl)phenyl]sulfanyl}phenyl)acetate

methyl 2-(4-hydroxy-3-{[2-hydroxy-5-(2-methoxy-2-oxoethyl)phenyl]sulfanyl}phenyl)acetate

C18H18O6S (362.08240480000006)


   

6,6-dimethyl-5,12,18,20,24-pentaoxahexacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²³.0¹⁷,²¹]tetracosa-1(14),2(11),3,7,9,15(23),16,21-octaen-13-one

6,6-dimethyl-5,12,18,20,24-pentaoxahexacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²³.0¹⁷,²¹]tetracosa-1(14),2(11),3,7,9,15(23),16,21-octaen-13-one

C21H14O6 (362.0790344)


   

5-hydroxy-3-(4-hydroxy-5-methyl-2-oxochromen-3-yl)-2-methylnaphthalene-1,4-dione

5-hydroxy-3-(4-hydroxy-5-methyl-2-oxochromen-3-yl)-2-methylnaphthalene-1,4-dione

C21H14O6 (362.0790344)


   

(1r,1'r,10'r,12'r)-7'-hydroxy-5-methoxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione

(1r,1'r,10'r,12'r)-7'-hydroxy-5-methoxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione

C21H14O6 (362.0790344)


   

7'-hydroxy-5-methoxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione

7'-hydroxy-5-methoxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione

C21H14O6 (362.0790344)


   

(1s)-7-methoxy-1-methyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁶,²⁰]icosa-2(11),3,6,9,13(20),15-hexaene-5,8,12,17-tetrone

(1s)-7-methoxy-1-methyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁶,²⁰]icosa-2(11),3,6,9,13(20),15-hexaene-5,8,12,17-tetrone

C21H14O6 (362.0790344)


   

(6s)-6-(prop-1-en-2-yl)-7,11,17,19,23-pentaoxahexacyclo[11.10.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tricosa-1(13),2(10),3,8,14(22),15,20-heptaen-12-one

(6s)-6-(prop-1-en-2-yl)-7,11,17,19,23-pentaoxahexacyclo[11.10.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tricosa-1(13),2(10),3,8,14(22),15,20-heptaen-12-one

C21H14O6 (362.0790344)


   

methyl 5,7-dihydroxy-2-methyl-6,11-dioxotetracene-1-carboxylate

methyl 5,7-dihydroxy-2-methyl-6,11-dioxotetracene-1-carboxylate

C21H14O6 (362.0790344)